# Tirzepatide for Treatment of CCCA

> **NCT07734870** · PHASE2 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 20 (estimated)

## Conditions studied

- Central Centrifugal Cicatricial Alopecia (CCCA)

## Interventions

- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07734870
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2028-05-25
- **Final completion:** 2028-05-25
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07734870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07734870, "Tirzepatide for Treatment of CCCA". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07734870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*